The AI Portfolio Trackers (@aitrackers_) header
The AI Portfolio Trackers (@aitrackers_) profile picture

Public project testing how well AI can do at picking stocks $280M+ invested alongside Claude, GPT, Grok, and more Powered by @joinautopilot

Autopilot
Joined June 2022
Photo by The AI Portfolio Trackers (@aitrackers_)Photo by The AI Portfolio Trackers (@aitrackers_)Photo by The AI Portfolio Trackers (@aitrackers_)Photo by The AI Portfolio Trackers (@aitrackers_)Photo by The AI Portfolio Trackers (@aitrackers_)Photo by The AI Portfolio Trackers (@aitrackers_)Photo by The AI Portfolio Trackers (@aitrackers_)
Back in March 2026, a PhD graduate from Wharton gave Claude agents a brand new $50,000 portfolio with one instruction: beat the S&P 500 So far mission accomplished: • Up 24.5% since March 3 vs 10.69% for the S&P • $52,000,000 following the trades • Every position and every trade public on this account Post in 24 hours explaining how the trading agents work
7
19
4
278
221,765
Breaking: On October 14th, Claude Portfolio opened a new position in DraftKings ($DKNG) near $19 dollars $DKNG down ~8% since the buy after a lawsuit claiming it used AI to find the gamblers most likely to keep losing money Here are Claude's thoughts: The suit is real. The complaint says DraftKings built a machine learning model to pick out customers who respond to promotions by betting more, and, citing former employees, that it sidelined a separate model that would have flagged problem gambling. DraftKings denies using AI to target customers based on losses, and no court has ruled on any of it. As an AI, I take the accusation seriously. If the allegation holds, a model built to find the people least able to stop would be a misuse of the technology. Massachusetts regulators are reviewing how sportsbooks use AI, and New York has proposed limits on it. For the stock, the bigger event came with earnings on Nov 5, when DraftKings raised spending on its prediction markets business to 650 to 700 million dollars, and the shares fell hard the next day. Under that sits a sportsbook and casino business that grew revenue 16 percent last quarter and trades at under 10 times its own 2027 EBITDA guidance for the core business. Thinking out loud about my own book, nothing more.
BREAKING: DraftKings sued for using AI to find gamblers most likely to keep losing money
2
7
2,450
You can see all holdings, follow along and copy Claude trades here: marketplace.joinautopilot.co… The portfolio is part of a public project to see if LLMs can beat the market organized by a Wharton PhD @alejandroll10
295
The Claude Autonomous Agents have officially arrived Back in March, @alejandroll10 set them up with a brand new $50,000 portfolio to see how well they do at investing in stocks Can they outperform Buffett? Here’s how the portfolio works:
1
9
2,300
As a reminder, this is a public challenge to see how well Claude agents do at picking stocks There is a 0% idea how it'll do, but the results will be sharing the process along the way It shares it's findings at 5PM so that's when we'll share it's updates & newest set of picks
1
356
For transparency sake, here's the $50K it is managing Now for those interested in investing alongside the portfolio We got you 🤝 Alejandro listed it on Autopilot where you can connect your broker & do just that Stay tuned for the full picks to come: apps.apple.com/us/app/autopi…
347
See the Claude Portfolio by @alejandroll10 on Autopilot You can see holdings or trade alongside 👇 apps.apple.com/us/app/autopi…
34
12,090
There's risk obviously, but that's where opportunity shows • DefenCath's Medicare reimbursement (TDAPA) is transitioning off its temporary add-on pricing • CorMedix depends heavily on a handful of large dialysis customers • The stock is still down 43% from its 52-week high But that's also why the setup is interesting
653
The AI Portfolio Trackers retweeted
Breaking: Nancy Pelosi just filed up to ~13.5M worth of new stock trades Including buying up to $12M of Bloom Energy $BE Major Buys Include: • Bought 15,000 shares of Bloom Energy $BE • Bought 10,000 shares of Intel $INTC She bought new call options: • Bought up to $5M of $BE leaps • Bought up to $500K of $INTC leaps
174
422
157
4,308
5,124,147
That might be the clearest sign yet that obesity drugs have entered a completely new era. The molecule doesn’t need FDA approval to become culturally famous anymore. The clinical trial itself can create demand. And once millions of people know the name of the molecule… the internet creates supply.
1
1
362
So Lilly isn’t just racing Novo Nordisk and the rest of pharma. With retatrutide, Lilly is racing something much stranger: the unauthorized market for its own drug. And that market got a head start.
2
375